Finland· FI-REL-REL62941
Gazoron
A granisetron product containing granisetron hydrochloride, registered in Finland by STADA Arzneimittel AG. The same ATC class is registered in 18 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Granisetron is registered in 18 of 19 countries.
Countries holding a registration under ATC A04AA02 (granisetron), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 10 of them publish a price we can compare per daily dose
Granisetron · ATC A04AA02
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of granisetron costs, country by country.
Normalised to the WHO defined daily dose (2 mg), the median price runs from $10.02 in Italy to $29.01 in Switzerland — a ×2.9 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Granisetron · price per daily dose (2 mg)
USD · FX 28 Sept 2026
- CH Switzerland$29.01
- FR France$11.60
- IT Italy$10.02
The record
At a glance
Fimea (Finland)- Active substance
- Granisetron hydrochloride
- Manufacturer
- STADA Arzneimittel AG
- Country
- Finland (FI)
- ATC code
- A04AA02
- ATC class
- Granisetron
- Defined daily dose
- 2 mg, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
564 interactions on record for granisetron.
Graded by severity as the source publishes them — 139 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Granisetron · interactions on record
564 records
- 139 severe
- 244 moderate
- 9 minor
- 172 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- FenfluramineA08AA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Granisetron in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaGRANEGISEgis Pharmaceuticals PLC, Budapešť
- ItalyGRANDISELANOVA FARMACEUTICI S.R.L.
- NetherlandsGranisetron Aurobindo 2 mg, filmomhulde tablettenAurobindo Pharma B.V.
- SwitzerlandKytril
- SwedenGranisetron STADA 2 mg Filmdragerad tablettSTADA Arzneimittel AG
- IrelandKytril 2mg film-coated tabletsAtnahs Pharma Netherlands B.V.
- FranceKYTRIL 2 mg, comprimé pelliculéATNAHS PHARMA NETHERLANDS (PAYS-BAS)
- IcelandGRANEMS.F. Group S.r.l.
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Granisetron Actavis, Kytril
- Belgium · Granisetron Fresenius Kabi, Kytril
- Bulgaria · Расетрон
- Czechia · Granegis, Granisetron Kabi
- Germany · Grani, Granisetron Baxter
- Denmark · Granisetron Hameln, Granisetron Stada
- Estonia · Kytril
- Spain · Granisetrón Altan, Granisetrón Aurovitas Spain
- France · Kytril
- United Kingdom (Northern Ireland) · Granisetron, Granisetron Dawa
- Greece · Granitron, Viatrinil 1mg/Ml
- Croatia · Granizetron Kabi
- Hungary · Granegis, Granigen
- Ireland · Kytril
- Iceland · Grandise, Granem
- Italy · Grandise, Granem
- Liechtenstein · Sancuso
- Malta · Granisetron Sigillata
- Netherlands · Granisetron Baxter, Granisetron Fresenius Kabi
- Norway · Sancuso
- Portugal · Granisetron Orchid Europe, Granissetrom Aurovitas
- Romania · Granisetron Kabi, Granisetron Labormed
- Sweden · Granisetron Fresenius Kabi, Granisetron Hameln
- Slovenia · Granisetron Lek, Kytril
- Slovakia · Emegar, Granegis
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6e0da232-fef7-41d0-ba94-2b83d6badd1b GET /v1/drugs/6e0da232-fef7-41d0-ba94-2b83d6badd1b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "2",
"form": "tabletti, kalvopäällysteinen",
"route": "Suun kautta",
"ddd_unit": "mg",
"strength": "2 mg",
"atc_label": "granisetroni",
"ma_number": "43880",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL62941",
"authorised_at": "2026-02-19"
}See everything about granisetron.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.